NasdaqGS - Delayed Quote USD

Quince Therapeutics, Inc. (QNCX)

1.0600 +0.0300 (+2.91%)
At close: April 26 at 4:00 PM EDT
1.0000 -0.06 (-5.66%)
After hours: April 26 at 6:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
27,142.0000
27,142.0000
51,190.0000
90,318.0000
78,893.0000
Operating Income
-27,142.0000
-27,142.0000
-51,190.0000
-90,318.0000
-78,893.0000
Net Non Operating Interest Income Expense
3,478.0000
3,478.0000
1,068.0000
620.0000
2,044.0000
Other Income Expense
-7,918.0000
-7,918.0000
-1,822.0000
-247.0000
--
Pretax Income
-31,582.0000
-31,582.0000
-51,944.0000
-89,945.0000
-76,849.0000
Tax Provision
-197.0000
-197.0000
-284.0000
--
--
Net Income Common Stockholders
-31,385.0000
-31,385.0000
-51,660.0000
-89,945.0000
-76,849.0000
Diluted NI Available to Com Stockholders
-31,385.0000
-31,385.0000
-51,660.0000
-89,945.0000
-76,849.0000
Basic EPS
-0.84
--
-1.54
-3.03
-2.63
Diluted EPS
-0.84
--
-1.54
-3.03
-2.63
Basic Average Shares
37,237.1490
--
33,496.5340
29,718.5060
29,176.2320
Diluted Average Shares
37,237.1490
--
33,496.5340
29,718.5060
29,176.2320
Total Operating Income as Reported
-34,620.0000
-34,620.0000
-52,015.0000
-90,318.0000
-78,893.0000
Total Expenses
27,142.0000
27,142.0000
51,190.0000
90,318.0000
78,893.0000
Net Income from Continuing & Discontinued Operation
-31,385.0000
-31,385.0000
-51,660.0000
-89,945.0000
-76,849.0000
Normalized Income
-23,953.3636
-23,953.3636
-50,839.5375
-89,945.0000
-76,849.0000
Interest Income
3,478.0000
3,478.0000
1,068.0000
620.0000
2,044.0000
Net Interest Income
3,478.0000
3,478.0000
1,068.0000
620.0000
2,044.0000
EBIT
-27,142.0000
-27,142.0000
-51,190.0000
-90,318.0000
-78,893.0000
EBITDA
-26,820.0000
-26,820.0000
-50,986.0000
-89,974.0000
-78,561.0000
Reconciled Depreciation
322.0000
322.0000
204.0000
344.0000
332.0000
Net Income from Continuing Operation Net Minority Interest
-31,385.0000
-31,385.0000
-51,660.0000
-89,945.0000
-76,849.0000
Total Unusual Items Excluding Goodwill
-7,478.0000
-7,478.0000
-825.0000
--
--
Total Unusual Items
-7,478.0000
-7,478.0000
-825.0000
--
--
Normalized EBITDA
-19,342.0000
-19,342.0000
-50,161.0000
-89,974.0000
-78,561.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
--
--
Tax Effect of Unusual Items
-46.3636
-46.3636
-4.5375
--
--
12/31/2020 - 5/9/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DYAI Dyadic International, Inc.
1.4900
0.00%
 
DOMH Dominari Holdings Inc.
2.7000
-0.37%
 
MTEM Molecular Templates, Inc.
1.7050
+7.23%
 
DVHGF Devonian Health Group Inc.
0.1689
0.00%
 
SRBCF Sirona Biochem Corp.
0.0520
0.00%
 
EVG.L Theracryf Plc
0.8000
0.00%
 
BCDAW BioCardia, Inc.
0.0223
-16.79%
 
GRI GRI Bio, Inc.
0.4300
-1.35%
 
UCBJY UCB SA
66.48
-0.55%
 
DRMA Dermata Therapeutics, Inc.
0.3427
-3.74%